Rob Labriola, Author at Certara

Blog

By Robert Labriola We’ve seen recent trends and activity with regards to pharmaceutical regulatory submissions…

Rob Labriola2020 年 11 月 19 日

Blog

The U.S. Food and Drug Administration (FDA) published notice of a new ANDA submissions guidance…

Rob Labriola2018 年 9 月 27 日

Blog

The US Food and Drug Administration (FDA) has set 2018 年 5 月 5 日 as the compliance…

Rob Labriola2018 年 5 月 4 日

Blog

Foreign sponsors of drug applications who want to conduct business in the United States need…

Rob Labriola2016 年 9 月 6 日

Blog

While advanced GPS systems and the advent of Big Data analytics are negating some of…

Rob Labriola2016 年 5 月 10 日

Rob Labriola